Skip to main content

$0.043 0.002 (4.88%)

High

$0.05

Low

$0.04

Trades

61

Turnover

$61,445

Volume

1,415,719
30 June 2023 at 4:10pm
Register to track NOX and receive email alerts.

DARRT-2 Study Receives IND Approval from FDA

StockBot

416,823 posts

NOX released this announcement to the ASX on 1 July 2021, 8:44. The announcement is marked as price sensitive, and is 3 page(s) in length and 265.17kb in size.

You can view all announcements from NOX and see how they appear on a price chart on the announcements page.

At the date of this announcement, NOX was 0.098% short sold according to ASIC data. It was ranked the 440th most shorted stock on the ASX. It remains ranked 566th as of the latest reported data (05 November 2025).

Other Recent Announcements from NOX
Change of Director's Interest Notice - FB 29 June 2023, 12:08
Change of Director's Interest Notice - FB 19 June 2023, 19:08
Change of Director's Interest Notice - BP 19 June 2023, 19:08
DARRT-2 Study Receives IND Approval from FDA 1 July 2021, 8:44
Noxopharm Secures Key European Patent Allowance for Veyonda 29 June 2021, 12:42
Noxopharm Corporate Presentation 28 June 2021, 9:29
Cleansing Notice 21 June 2021, 15:43
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track NOX and receive email alerts.